Using virtual reality to prepare lung transplant patients for ICU admission
Intensive Care Unit-specific Virtual Reality As Preparation for ICU Admission in Lung Transplant Patients
This study tests if using virtual reality can help lung transplant patients feel more prepared and less anxious about their upcoming stay in the ICU.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 71 Years |
| Sex | All |
| Sponsor | Erasmus Medical Center Academic / other |
| Locations | 1 site (Rotterdam, South Holland) |
| Trial ID | NCT06642636 on ClinicalTrials.gov |
What this trial studies
This study evaluates the use of Intensive Care Unit-specific Virtual Reality (ICU-VR) to help lung transplant patients prepare for their upcoming ICU admission. The aim is to provide information and improve patients' perspectives, potentially reducing psychological impairments associated with ICU stays. The study is designed as a monocentre randomized controlled trial at Erasmus Medical Center, focusing on patients aged 18-71 who are on the lung transplant waiting list and understand Dutch. Participants will engage with the ICU-VR intervention developed by a team of healthcare professionals.
Who should consider this trial
Good fit: Ideal candidates are lung transplant patients aged 18-71 who are on the waiting list and can understand the Dutch language.
Not a fit: Patients who do not meet the age or language requirements, or those not on the lung transplant waiting list, may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the incidence of psychological impairments like PTSD and depression in lung transplant patients post-ICU.
How similar studies have performed: While the use of virtual reality in healthcare is gaining traction, this specific application for lung transplant patients in the ICU context is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: * Be on the waiting list for lung transplantation * Age 18-71 years (maximum age for lung transplantation is 71 years) * Understand the Dutch language * Signed informed consent Exclusion Criteria: While patients on the waiting list for lung transplantation are intensively monitored and only placed on the waiting list under strict conditions, no additional exclusion criteria above these are identified to exclude specific patients.
Where this trial is running
Rotterdam, South Holland
- Erasmus Medical Center — Rotterdam, South Holland, Netherlands (Recruiting)
Study contacts
- Study coordinator: Denzel LQ Drop, MD
- Email: d.drop@erasmusmc.nl
- Phone: 0031629659221
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.